article

Stem Cell In-Depth Focus 2019

Posted: 5 June 2019 | | 1 comment

This in-depth focus looks at the modification of stem cells to facilitate their efficient delivery to tumours, highlighting the new development of pluripotent stem cells.

    To read this In-Depth Focus in full, please complete the form below. By clicking submit you confirm that you accept our terms and conditions and privacy policy.


    *


    *


    *


    *


    *


    *


    *


    *

    This content is provided to you for free thanks to the kind support of our sponsors: Biocon Research Limited, Montreal Neurological Institute, McGill University

    I am happy for my details to be shared with the sponsors

    Included in this In-Depth Focus:

    • Stem-cell technologies in immunotherapy
      In recent years scientists have developed many therapeutic molecules – such as bifunctional multi-targeting antibodies, fusion proteins and oncolytic viruses – and different types of stem cells are being modified to facilitate their efficient delivery to tumours, illustrating the great potential of engineered therapeutic stem cells. In this article, Aparajita Dubey, Associate Scientific Manager at Biocon biologics Limited, outlines the exciting developments that are taking place with immunotherapies and demonstrates how stem-cell technologies are proliferating the paradigm shift in how we tackle cancer treatment.
    • Using stem cells to study the effects of cannabis on neuronal development
      Thanks to new developments with induced pluripotent stem cells enabling generation of human neurons, scientists can more precisely analyse the effects that chemicals have on human cells. Trisha Rao, Montreal Neurological Institute, and Thomas Durcan, McGill University, expand on their research into the effects of cannabis on neuronal development and implications of its legalisation in Canada.